Reduction of calcineurin enzymatic activity in Alzheimer's disease: Correlation with neuropathologic changes

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 8, 1996, Pages 924-931

  Ladner, Christopher J ^a   Czech, Julie ^a   Maurice, Joanna ^a   Lorens, Stanley A ^a   Lee, John M ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Calcineurin; Neuropathology

Indexed keywords

4 NITROPHENYL PHOSPHATE; CALCINEURIN; CYCLOSPORIN A; MANGANESE CHLORIDE; NICKEL CHLORIDE; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; OCCIPITAL CORTEX; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SENILE PLAQUE; TEMPORAL CORTEX;

EID: 0029798880     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199608000-00008     Document Type: Review

References (52)

1. Roth M, Tomlinson BE, Blessed G. Correlation between the scores for dementia and counts of "senile plaques" in cerebral gray matter of elderly subjects. Nature 1966;209:109-10
2. Wilcock GK, Esiri MM. Plaques, tangles and dementia. A quantitative study. J Neurol Sci 1982;56:343-56
3. McKee AC, Kosik KS, Kowall NW. Neuritic pathology and dementia in Alzheimer's disease. Ann Neurol 1991;30:156-65
4. Arriagada PV, Growdon JH, Hedley-White ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity in Alzheimer's disease. Neurol 1992;42:631-39
5. Berg L, McKeel DW, Miller JP, Baty J, Morris JC. Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older. Arch Neurol 1993;50:349-58
6. Samuel W, Terry RD, DeTeresa R, Butters N, Masliah E. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch Neurol 1994;51:772-78
7. Bierer LM, Hof PR, Purohit DP, et al. Neocortical neurofibrillary tangles correlate with dementia severity of Alzheimer's disease. Arch Neurol 1995;52:81-88
8. Goedert M. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease. Arzneim-Forsch/Drug Res 1995;45:403-9
9. Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986:83:4913-17
10. Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM-Y. Abnormal tau phosphorylation at Ser(396) in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993;10:1089-99
11. Mandelkow E-M, Biernat J, Drewes G, Gustke N, Trinczek B, Manelkow, E. Tau domains, phosphorylation, and interactions with microtubules. Neurobiol of Aging 1995;16:355-62
12. Wang J-Z, Gong C-X, Zaidi T, Grundke-Iqbal I, Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and/-2B. J Biol Chem 1995;270:4854-60
13. Baumann K, Mandelkow E-M, Biernat J, Piwnica-Worms H, Mandelkow E. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS 1993;336:417-24
14. Paudel HK, Lew J, Zenobia A, Wang JH. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J Biol Chem 1993;268:23512-18
15. Singh TJ, Haque N, Grundke-Iqbal I, Iqbal K. Rapid Alzheimerlike phosphorylation of tau by the synergistic actions of nonproline-dependent protein kinases and GSK-3. FEBS 1995;358: 267-72
16. Drewes G, Mandelkow E-M, Baumann K, Goris J, Merlevede W, Mandelkow E. Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase 2A. FEBS Lett 1993;336:425-32
17. Gong C-X, Singh TJ, Grundke-Iqbal I, Iqbal K. Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin). J Neurochem 1994;62:803-6
18. Gong C-X, Grundke-Iqbal I, Iqbal K. Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase 2A. Neuroscience 1994;61:765-72
19. Saitoh Y, Yamamoto H, Ushio Y, Miyamoto E. Characterization of polyclonal antibodies to brain protein phosphatase 2A and immunohistochemical localization of the enzyme in rat brain. Brain Res 1989;489:291-301
20. Pei J-J, Sersen E, Iqbal K, Grundke-Iqbal I. Expression of protein phosphatases (PP-1, PP-2A, PP-2B, and PTP-1B) and protein kinases (MAP kinase and P34cdc2) in the hippocampus of patients with Alzheimer disease and normal aged individuals. Brain Res 1994;655:70-76
21. Goto S, Matsukado Y, Mihara Y, Inoue N, Miyamoto E. Calcineurin in human brain and its relation to extrapyramidal system. Acta Neuropathol 1986;72:150-56
22. Billingsley ML, Ellis C, Kincaid RL, et al. Calcineurin immunoreactivity in Alzheimer's disease. Exp Neurol 1994;126:178-84
23. Ingebritsen S, Stewart AA, Cohen P. The protein phosphatases involved in cellular regulation. Eur J Biochem 1983;132:297-307
24. Pallen CJ, Wang JH. Calmodulin-stimulated dephosphorylation of p-nitrophenyl phosphate and free phosphotyrosine by calcineurin. J Biol Chem 1983;258:8550-53
25. Seki K, Chen H-C, Huang K-P. Dephosphorylation of protein kinase C substrates, neurogranin, neuromodulin, and MARCKS, by calcineurin and protein phosphatases 1 and 2A. Arch Biochem Biophys 1995;316:673-79
26. 2+/calmodulin-dependent protein phosphatase (2B) from rabbit skeletal muscle. Eur J Biochem 1983;132:289-95
27. Ishihara H, Martin BL, Brautigan DL, et al. Calyculin A and okadaic acid: Inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 1989;159:871-77
28. Garver TD, Oyler GA, Harris KA, et al. Tau phosphorylation in brain slices: Pharmacological evidence for convergent effects of protein phosphatases on tau and mitogen-activated protein kinase. Mol Pharmacol 1995;47:745-56
29. Liu J. FK506 and ciclosporin: Molecular probes for studying intracellular signal transduction. Trends in Pharm Sci 1993:182-88
30. Kayyali US, Zhang W, Yee AG, Seidman J, Potter H. Accumulation of hyperphosphorylated tau in knock-out mice lacking calcineurin. Soc Neurosci Abst 1995;21(1):742
31. Matsuo ES, Shin R-W, Billingsley ML, et al. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 1994;13: 989-1002
32. Shimohama S, Fujimoto S, Taniguchi T, Kameyama M, Kimura J. Reduction of low-molecular weight acid phosphatase activity in Alzheimer brains. Ann Neurol 1993;33:616-21
33. Gong C-X, Singh TJ, Grundke-Iqbal I, Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 1993;61:921-27
34. Gong C-X, Shaikj S, Wang J-Z, Zaidi T, Grundke-Iqbal I, Iqbal K. Phosphatase activity toward abnormally phosphorylated tau: Decrease in Alzheimer disease brain. J Neurochem 1995;65:732-38
35. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Neurology 1991;41: 479-86
36. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976;72:248-54
37. Takai A, Ohno Y, Yasumoto T, Mieskes G. Estimation of the rate constants associated with the inhibitory effect of okadaic acid on type 2A protein phosphatase by time-course analysis. Biochem J 1992;287:101-6
38. Klee CB, Crouch TH, Krinks MH. Calcineurin: A calcium- and calmodulin-binding protein of the nervous system. Proc Natl Acad Sci 1979;76:6270-73
39. 2+-dependent inactivation of calcineurin in brain. FEBS Lett 1995;374:237-40
40. Wood JG, Wallace RW, Whitaker JN, Cheung WY. Immunocytochemical localization of calmodulin and a heat-labile calmodulinbinding protein (CaM-BP80) in basal ganglia of mouse brain. J Cell Biol 1980;84:66-76
41. Mountjoy CQ, Roth M, Evans NJR, Evans HM. Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol Aging 1983;4:1-11
42. Hof PR, Cox K, Morrison JH. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J Comp Neurol 1990;301:44-54
43. Pallen CJ, Valentine KA, Wang JH, Hollenberg MD. Calcineurinmediated dephosphorylation of the human placental membrane receptor for epidermal growth factor urogastrone. Biochem 1985;24: 4727-30
44. Shapiro IP, Masliah E, Saitoh T. Altered protein tyrosine phosphorylation in Alzheimer's disease. J Neurochem 1991;56:1154-62
45. Vener AV, Aksenova MV, Burbaeva GS. Drastic reduction in zincand magnesium-stimulated protein tyrosine kinase activities in Alzheimer's disease hippocampus. FEBS Lett 1993;328:6-8
46. Wood JG, Zinsmeister P. Tyrosine phosphorylation systems in Alzheimer's disease pathology. Neurosci Lett 1991;121:12-16
47. Schmidt ML, DiDario AG, Otvos L, et al. Plaque-associated neuronal proteins: A recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain. Exp Neurol 1994;130:311-22
48. Alexander DR, Hexham JM, Crumpton MJ. The association of type 1, type 2A and type 2B phosphatases with the human T lymphocyte plasma membrane. Biochem J 1988;256:885-92
49. Coghlan VM, Perrino BA, Howard M, et al. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 1995;267:108-11
50. 2+-dependent phosphatase. Nature 1994;369:235-39
51. Nichols RA, Suplick GR, Brown JM. Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate. J Biol Chem 1994;269:23817-23
52. Victor RG, Thomas GD, Marban E, O'Rourke B. Presynaptic modulation of cortical synaptic activity by calcineurin. Proc Natl Acad Sci USA 1995;92:6269-73